Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $13.10 in the last session, down -3.32% from day before closing price of $13.55. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
We take a closer look at KALV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.44 and its Current Ratio is at 10.44. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on January 31, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $19.
On January 07, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $30.
On December 18, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.BofA Securities initiated its Buy rating on December 18, 2024, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 09 ’25 when Venrock Healthcare Capital Par bought 25,000 shares for $9.42 per share. The transaction valued at 235,500 led to the insider holds 5,303,985 shares of the business.
Palleiko Benjamin L sold 6,669 shares of KALV for $79,828 on Mar 07 ’25. The CHIEF EXECUTIVE OFFICER now owns 287,811 shares after completing the transaction at $11.97 per share. On Feb 24 ’25, another insider, Audhya Paul K., who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,394 shares for $10.02 each. As a result, the insider received 23,988 and left with 102,940 shares of the company.
Stock Price History:
Over the past 52 weeks, KALV has reached a high of $15.50, while it has fallen to a 52-week low of $7.30. The 50-Day Moving Average of the stock is 9.84%, while the 200-Day Moving Average is calculated to be 18.29%.
Shares Statistics:
A total of 49.49M shares are outstanding, with a floating share count of 38.53M. Insiders hold about 22.49% of the company’s shares, while institutions hold 89.86% stake in the company.
